Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 1/20 | 0.54 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.49 |
| ▸ | MAOB | P27338 | 5/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | PARP15 | Q460N3 | 1/20 | 0.42 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.42 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.42 |
| ▸ | PTPN2 | P17706 | 2/20 | 0.42 |
| ▸ | CDC25B | P30305 | 2/20 | 0.42 |
| ▸ | MMP13 | P45452 | 1/20 | 0.42 |
| ▸ | MME | P08473 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.41 |
| ▸ | KDM5A | P29375 | 1/20 | 0.41 |
| ▸ | ACACB | O00763 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21580121 | 0.77 | SCN3A (0.52) | SCN9ASCN3AMAOBSMN1; SMN2PARP15 | |
| SCHEMBL21580096 | 0.77 | SCN3A (0.54) | SCN9ASCN3AMAOBSMN1; SMN2POLB | |
| SCHEMBL23686705 | 0.77 | ALDH1A1 (0.65) | SCN9ASCN3AMAOBSMN1; SMN2POLB | |
| SCHEMBL21580134 | 0.76 | SCN3A (0.55) | SCN9ASCN3AMAOBSMN1; SMN2PARP15 | |
| SCHEMBL21580127 | 0.75 | SCN3A (0.52) | SCN9ASCN3AMAOBSMN1; SMN2POLB | |
| SCHEMBL8935452 | 0.75 | SCN9A (0.68) | SCN9ASCN3AMAOBPARP15PARP14 | |
| SCHEMBL31206947 | 0.75 | MME (0.49) | SMN1; SMN2MMEKDM5A | |
| SCHEMBL21580116 | 0.74 | SCN3A (0.51) | SCN9ASCN3AMAOBSMN1; SMN2PARP15 | |
| SCHEMBL21580126 | 0.74 | SCN3A (0.56) | SCN9ASCN3AMAOBSMN1; SMN2POLB | |
| SCHEMBL8935432 | 0.73 | SCN3A (0.66) | SCN9ASCN3AMAOBSMN1; SMN2PARP15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210230157-A1 | PAIN TREATING COMPOUNDS AND USES THEREOF | BIONOMICS LIMITED (AU) | 2021-07-29 | — | — | US | disclosed |
| WO-2019218024-A1 | PAIN TREATING COMPOUNDS AND USES THEREOF | BIONOMICS LIMITED (AU) | 2019-11-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210230157-A1 | PAIN TREATING COMPOUNDS AND USES THEREOF | TRPV1, TRPA1, TRPV3 | SCN9A 190/4885SCN3A 46/4885MAOB 1123/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.